Loading…
SUNLENCA (lenacapavir) is a twice-yearly injectable prescription medicine used in combination with other HIV-1 medicines to treat adults with hard-to-treat HIV-1 infection who have resistance to many HIV-1 medicines and whose current treatment is failing. It does not cure HIV-1 or AIDS.
AI named Lenacapavir in January 2026.